¼¼°è ±â¸éÁõ Ä¡·áÁ¦ ½ÃÀå : À¯Çüº°, Á¦Ç°º°, ±¹°¡º°, Áö¿ªº° »ê¾÷ ºÐ¼® - ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À² ¹× ¿¹Ãø(2023³â-2030³â)
Narcolepsy Therapeutics Market, By Type, By Product, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
»óǰÄÚµå : 1419095
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 322 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,475,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,403,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,781,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

º¸°í¼­ ÇÏÀ̶óÀÌÆ®

±â¸éÁõ Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð´Â 2022³â¿¡ 34¾ï 3,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2023³âºÎÅÍ 2030³â¿¡ °ÉÃÄ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 8.34%·Î È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

±â¸éÁõ Ä¡·áÁ¦ ½ÃÀå - ½ÃÀå ¿ªÇÐ

¼ö¸éÀå¾Ö À¯º´·ü Áõ°¡, R&D Ȱµ¿ ¹× ÅõÀÚ Áõ°¡°¡ ½ÃÀå ¼ö¿ä ÃËÁø

¿¬±¸°³¹ßºñ¿Í Ȱµ¿ Áõ°¡, Áúº´ À¯º´·ü »ó½Â, Çõ½ÅÀûÀÎ ÀǾàǰ Ãâ½Ã´Â ½ÃÀå È®´ë¸¦ µÞ¹ÞħÇÏ´Â ÁÖ¿ä ¿äÀÎÀÇ ÀϺÎÀÔ´Ï´Ù. ¹Ì±¹ ±¹¸³½Å°æÁúȯ¡¤³úÁ¹Áß¿¬±¸¼Ò(NINDS)ÀÇ Ãß°è¿¡ ÀÇÇϸé, ±â¸éÁõ´Â ¹Ì±¹¿¡¼­ 13¸¸ 5,000-20¸¸¸íÀÌ ÀÌȯÇϰí ÀÖ½À´Ï´Ù. ÇâÈÄ ¸î ³âµ¿¾È, ³­ÄÝ·¾½Ã·Î Áø´Ü¹Þ´Â »ç¶÷ÀÇ ¼ö°¡ Áõ°¡ÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå È®´ë¸¦ ÃËÁøÇÏ´Â ¿äÀÎ Áß Çϳª´Â ȯÀÚ ¼ö Áõ°¡ÀÔ´Ï´Ù. National Organization for Rare Disorders¿¡ µû¸£¸é ¾à 2,000¸í Áß 1¸íÀÌ ÀÌ ÁúȯÀ» ¾Î°í ÀÖ½À´Ï´Ù. ¸¶Âù°¡Áö·Î, ¹Ì±¹ ¹Ì±¹ ½Å°æÇÐȸ(American Academy of Neurology)ÀÇ Á¶»ç¿¡¼­ À¯º´·üÀº Àα¸ 10¸¸¸í´ç 20-60¸íÀ¸·Î µÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀåÀÌ È®´ëµÇ°í ÀÖ´Â ÀÌÀ¯´Â Áúº´ Ä¡·á¿¡ »õ·Î¿î Ä¡·á¹ýÀ» µµÀÔÇϱâ À§ÇÑ ¿¬±¸°³¹ß(R&D)ÀÇ ³ë·ÂÀÌ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ÃÖ±Ù ¿¬±¸°³¹ß Ȱµ¿ÀÇ °¡¼ÓÈ­·Î ÇâÈÄ ¸î³â¾È¿¡ »õ·Î¿î Ä¡·á¹ýÀÌ µµÀ﵃ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, 2021³â 5¿ù, ´ÙÄÉ´Ù ¾àǰ°ø¾÷ ÁÖ½Äȸ»ç´Â ±â¸éÁõ Ä¡·áÁ¦ÀÇ ¿¬±¸°³¹ßÀ» ¹ßÇ¥Çß½À´Ï´Ù.

±â¸éÁõ Ä¡·áÁ¦ ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

¼¼°è ±â¸éÁõ Ä¡·áÁ¦ ½ÃÀåÀº À¯Çü, Á¦Ç° ¹× Áö¿ª¿¡ µû¶ó ±¸ºÐµË´Ï´Ù.

À¯Çüº°·Î´Â īŸÇ÷º½ÃÀÇ À¯¹«·Î ºÐ·ùµË´Ï´Ù. ½ÃÀåÀ» µ¶Á¡ÇÏ´Â °ÍÀº īŸÇ÷º½Ã ºÎ¹®ÀÔ´Ï´Ù. ȯÀÚÀÇ ÁÖ¿ä Áõ»óÀ¸·Î īŸÇ÷º½Ã°¡ Áõ°¡Çϰí ÀÖ´Ù´Â °ÍÀº °°Àº ºÎ¹®ÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº Á¦Ç°¿¡ µû¶ó ÁßÃß ½Å°æ°è ÀÚ±ØÁ¦, ¿Á½Ãº£ÀÌÆ® ³ªÆ®·ý, »ïȯ°è Ç׿ì¿ïÁ¦·Î ºÐ·ùµË´Ï´Ù. ¿Á½Ãº£ÀÌÆ® ³ªÆ®·ýÀº ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç ¿¹Ãø ±â°£ µ¿¾È¿¡µµ ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ƯÀÌÇÑ ½Å°æÁúȯ ȯÀÚ¸¦ À§ÇÑ ÁßÃ߽ŰæÀÚ±ØÁ¦¿¡ ´ëÇÑ ¿¬±¸°³¹ß ³ë·Â Áõ°¡°¡ ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±â¸éÁõ Ä¡·áÁ¦ ½ÃÀå - Áö¸®Àû ÀλçÀÌÆ®

Áö¿ªÀûÀ¸·Î, ÀÌ ½ÃÀåÀº ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °¢ Áö¿ªÀ¸·Î ÆÛÁ® ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ºñÁî´Ï½º¸¦ Á¦°øÇÏ´Â ±¹°¡¿¡ ÀÇÇØ ´õ ³ª´¹´Ï´Ù.

±â¸éÁõ Ä¡·áÁ¦ ½ÃÀå - °æÀï ±¸µµ:

±â¸éÁõ Ä¡·áÁ¦ ½ÃÀåÀº ¼Ò¼öÀÇ ±â¾÷ÀÌ ¼¼°è ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖÀ¸¸ç, ±× Ư¼º»ó ´ÜÆíÈ­µÇÁö ¾Ê¾Ò½À´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº ±Þ¼ÓÇÑ ÅõÀÚ¿Í M&A¿Í ÇÔ²² ½ÅÁ¦Ç° ¼³°è¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î(2022³â) 5¿ù, Axsome Therapeutics, Inc.´Â ¹Ì±¹ ½ÃÀå¿¡¼­ Jazz Pharmaceuticals·ÎºÎÅÍ Sunosi¸¦ ȹµæÇß´Ù°í ¹ßÇ¥Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ±â¸éÁõ Ä¡·áÁ¦ ½ÃÀå °³¿ä

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ±â¸éÁõ Ä¡·áÁ¦ÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ±â¸éÁõ Ä¡·áÁ¦ ¾÷°èÀÇ Á¶»ç

Á¦5Àå ±â¸éÁõ Ä¡·áÁ¦ ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ±â¸éÁõ Ä¡·áÁ¦ ½ÃÀå »óȲ

Á¦7Àå ±â¸éÁõ Ä¡·áÁ¦ ½ÃÀå : À¯Çüº°

Á¦8Àå ±â¸éÁõ Ä¡·áÁ¦ ½ÃÀå : Á¦Ç°º°

Á¦9Àå ±â¸éÁõ Ä¡·áÁ¦ ½ÃÀå : Áö¿ªº°

Á¦10Àå ÁÖ¿ä º¥´õ ºÐ¼® : ±â¸éÁõ Ä¡·áÁ¦ ¾÷°è

Á¦11Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

BJH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Narcolepsy Therapeutics Market size was valued at USD 3,430 Million in 2022, expanding at a CAGR of 8.34% from 2023 to 2030.

A lifelong sleep illness that causes uncontrollably sudden episodes of extreme sleepiness called as narcolepsy which impacts all facets of a patient's life and makes daily tasks challenging. Narcolepsy can be treated symptomatically with medications that promote wakefulness and raise dopamine release at the presynaptic level.

Narcolepsy Therapeutics Market- Market Dynamics

Increasing prevalence of sleep disorder, increasing R&D activities & investments is to propel market demand

Increasing R&D expenditures and activities, rising disease prevalence, and the launch of innovative medicinal goods are some of the main causes propelling market expansion. Narcolepsy affects between 135,000 and 200,000 people in the United States, according to estimates from the National Institute of Neurological Disorders and Stroke (NINDS). In the upcoming years, there will likely be a rise in the number of people with narcolepsy diagnoses because the disease is more common in those who experience higher levels of stress. Over the forecast period, one of the key drivers propelling the market expansion is an increase in the patient base. As per the National Organization for Rare Disorders, around 1 in 2,000 individuals are affected with the condition. In a similar vein, the American Academy of Neurology study found that the prevalence of disease varies from 20 to 60 in 100,000 people.

The market is growing because of an increase in research and development (R&D) efforts to introduce novel therapeutic solutions for the treatment of disease. New treatment alternatives will be introduced in the upcoming years because of the recent acceleration of research and development activity. For example, in May 2021, Takeda Pharmaceutical Company Limited announced that research and development for narcolepsy medication.

Narcolepsy Therapeutics Market- Key Insights

Narcolepsy Therapeutics Market- Segmentation Analysis:

The Global Narcolepsy Therapeutics Market is segmented on the basis of Type, Product, and Region.

The market is divided into two categories based on Type: cataplexy and without cataplexy. The cataplexy segment dominates the market. The rise in a prevalence of cataplexy as a major symptom in patients is boosting the segment growth.

The market is divided into three categories based on Product: Central Nervous System Stimulants, Sodium Oxybate, and Tricyclic Antidepressants. The Sodium Oxybate segment dominates the market and is likely to maintain its dominance during the forecast period. It is anticipated that rising R&D efforts pertaining to CNS stimulants for patients with uncommon neurological illnesses will drive the segment's growth.

Narcolepsy Therapeutics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Narcolepsy Therapeutics Market- Competitive Landscape:

The Narcolepsy Therapeutics market is less fragmented in nature with few players dominating global market. Key players in the market are focused on new product design paired with the rapid investment and mergers & acquisitions. For example, in May 2022, Axsome Therapeutics, Inc. announced the attainment of Sunosi from Jazz Pharmaceuticals across U.S. market.

Recent Developments:

In May 2023, Avadel Pharmaceuticals received final U.S. FDA approval for its drug Lumryz for the treatment of narcolepsy.

In January 2022, the U.S. FDA approved Orphan Drug Exclusivity for Jazz Pharmaceuticals' Xywav for the treatment of idiopathic hypersomnia in adults.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NARCOLEPSY THERAPEUTICS MARKET KEY PLAYERS

GLOBAL NARCOLEPSY THERAPEUTICS MARKET, BY TYPE

GLOBAL NARCOLEPSY THERAPEUTICS MARKET, BY PRODUCT

GLOBAL NARCOLEPSY THERAPEUTICS MARKET, BY REGION

Table of Contents

1. Narcolepsy Therapeutics Market Overview

2. Executive Summary

3. Narcolepsy Therapeutics Key Market Trends

4. Narcolepsy Therapeutics Industry Study

5. Narcolepsy Therapeutics Market: COVID-19 Impact Analysis

6. Narcolepsy Therapeutics Market Landscape

7. Narcolepsy Therapeutics Market - By Type

8. Narcolepsy Therapeutics Market - By Product

9. Narcolepsy Therapeutics Market- By Geography

10. Key Vendor Analysis- Narcolepsy Therapeutics Industry

11. 360 Degree Analyst View

12. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â